Comments

vTv Therapeutics Insider Trading Activity

VTVTNASDAQ
Logo brought to you by Benzinga Data
Trade with Public
Trade with Public
$33.76
-0.87-2.51%
At close: Dec 15, 4:00 PM EST
$30.15
-3.61-10.69%
After Hours: Nov 18, 4:09 PM EST
OverviewNewsEarningsAnalyst Ratings

Insider Trades

Short InterestStock Report

vTv Therapeutics Insider Trading Activity | NASDAQ:VTVT | Benzinga

Track the latest vTv Therapeutics insider trading activity. Stay informed on recent buys, sells, and market impact for vTv Therapeutics stock.

What is Insider Activity?

Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.

What are vTv Therapeutics Inc Insiders Doing?

Insiders have report no purchases/sales in the last 30 days.

Notable Recent Insider Buys and Sales

There has been no Insider buying or selling in the last 90 days.

Ownership Statistics for vTv Therapeutics Inc

Shares Outstanding
3.938M
Insider Shares Owned
285.117K
Insider Percentage Owned
7.24%
Institutional Shares Held
290.541K
Institutional Percentage Held
7.38%
Nov 19, 2024Paul J SekhriPRES, CEO AND EXEC CHAIRPERSON5.00K$16.76$83.81KBUY∞5.00KNov 15 - Nov 18View
Nov 30, 2022JOHN FRYDIRECTOR61.00K$0.83$50.74KBUY∞61.00KNov 28 - Nov 29View
Dec 21, 2021Ronald O Perelman10% OWNER-87.00K$1.15-$100.05KSELL-0.24%36.52MDec 20View
Mar 02, 2021Rich Nelson—60.00K$2.86$171.60KBUY∞10.00KFeb 26View
Mar 02, 2021HERSH KOZLOV—10.00K$2.74$27.40KBUY66.67%25.00KFeb 26View
Dec 17, 2020Ronald O Perelman—625.00K$1.60$1.00MPURCHASE1.74%36.61MDec 17View
Dec 10, 2020Ronald O Perelman—625.00K$1.60$1.00MPURCHASE1.77%35.98MDec 10View
Nov 24, 2020Ronald O Perelman—625.00K$1.60$1.00MPURCHASE1.80%35.36MNov 24View
May 18, 2020HERSH KOZLOV—10.00K$3.00$30.00KPURCHASE200.00%15.00KMay 15View
May 12, 2020Ronald O Perelman—625.00K$1.60$1.00MPURCHASE1.83%34.73MMay 12View
Feb 25, 2020Ronald O Perelman—1.25M$1.60$2.00MPURCHASE3.80%34.11MFeb 25View
Jan 28, 2020Ronald O Perelman—1.25M$1.60$2.00MPURCHASE3.95%32.86MJan 28View
Jan 07, 2020Ronald O Perelman—1.25M$1.60$2.00MPURCHASE4.12%31.61MJan 07View
Dec 18, 2019Ronald O Perelman—1.37M$1.46$2.00MBUY4.73%30.36MDec 18View
Nov 26, 2019Ronald O Perelman—1.37M$1.46$2.00MBUY4.96%28.99MNov 26View
Nov 12, 2019Ronald O Perelman—1.37M$1.46$2.00MBUY5.22%27.62MNov 12View
Oct 24, 2019Ronald Perelman—1.37M$1.46$2.00MBUY5.51%26.25MOct 24View
Sep 27, 2019Ronald O Perelman—1.37M$1.46$2.00MBUY5.83%24.88MSep 27View
Sep 18, 2019Ronald O Perelman—606.06K$1.65$1.00MBUY2.65%23.51MSep 18View
Sep 17, 2019HERSH KOZLOV—5.00K$1.65$8.25KBUY∞5.00KSep 13View
Sep 11, 2019Ronald O Perelman—606.06K$1.65$1.00MBUY2.72%22.90MSep 11View
Sep 04, 2019Ronald O Perelman—606.06K$1.65$1.00MBUY2.79%22.29MSep 04View
Aug 22, 2019Ronald O Perelman—50.00K$1.38$69.00KBUY0.23%21.69MAug 22View
Aug 19, 2019Ronald O Perelman—150.00K$1.31$195.90KBUY0.70%21.64MAug 19View
Aug 06, 2019Ronald O Perelman—1.21M$1.65$2.00MBUY5.98%21.49MAug 06View
Jul 09, 2019Ronald O Perelman—1.21M$1.65$2.00MBUY6.36%20.28MJul 09View
Jun 26, 2019Ronald O Perelman—1.21M$1.65$2.00MBUY6.79%19.06MJun 25View
May 16, 2019Ronald O Perelman—1.36M$1.84$2.50MBUY8.24%17.85MMay 15View
Feb 28, 2019Ronald O Perelman10% OWNER815.22K$1.84$1.50MBUY5.20%16.49MFeb 28View
Feb 15, 2019Ronald O Perelman—815.22K$1.84$1.50MBUY5.48%15.68MFeb 14View
Jan 30, 2019Ronald O Perelman—815.22K$1.84$1.50MBUY5.80%14.86MJan 29View
Jan 18, 2019Ronald O Perelman—815.22K$1.84$1.50MBUY6.16%14.05MJan 16View
Dec 27, 2018Ronald O Perelman—815.22K$1.84$1.50MBUY6.57%13.23MDec 27View
Nov 30, 2018Ronald O Perelman—1.88M$1.33$2.50MBUY17.84%12.42MNov 29View
Nov 07, 2018Ronald O Perelman—1.88M$1.33$2.50MBUY21.71%10.54MNov 06View
Oct 01, 2018Ronald O Perelman—1.88M$1.33$2.50MBUY27.73%8.66MSep 27View
Sep 10, 2018Ronald O Perelman—1.88M$1.33$2.50MBUY38.37%6.78MSep 06View
Sep 06, 2018Paul G Savas—5.00K$1.00$5.00KBUY5.76%91.78KSep 06View
Aug 14, 2018Ronald O Perelman—570.78K$4.38$2.50MBUY13.19%4.90MAug 10View
Jul 10, 2018Ronald O Perelman—570.78K$4.38$2.50MBUY15.19%4.33MJul 06View
Jun 20, 2018Ronald O Perelman—570.78K$4.38$2.50MBUY17.91%3.76MJun 18View
May 29, 2018RONALD PERELMAN—570.78K$4.38$2.50MBUY21.82%3.19MMay 24View
Dec 27, 2017RONALD PERELMAN—50.00K$4.03$201.72KBUY1.95%2.62MDec 26View
Dec 07, 2017Paul G Savas—15.00K$4.56$68.36KBUY20.90%86.78KDec 06 - Dec 07View
Aug 24, 2017RONALD PERELMAN—20.00K$4.57$91.32KBUY0.79%2.57MAug 22View
Aug 16, 2017RONALD PERELMAN—10.00K$4.97$49.68KBUY0.39%2.55MAug 16View
Aug 15, 2017RONALD PERELMAN—50.00K$4.72$235.96KBUY2.01%2.54MAug 14 - Aug 15View
Aug 14, 2017RONALD PERELMAN—85.00K$4.13$350.86KBUY3.54%2.49MAug 10 - Aug 11View
May 15, 2017Paul G Savas—3.00K$5.18$15.54KBUY4.36%71.78KMay 12 - May 15View
Apr 03, 2017Paul G Savas—10.00K$6.50$64.96KBUY17.01%68.78KMar 30 - Mar 31View
May 31, 2016Paul G Savas—6.00K$5.67$34.03KBUY11.37%58.78KMay 27View
May 24, 2016Paul G Savas—1.26K$5.26$6.62KBUY2.44%52.78KMay 20 - May 24View
Apr 11, 2016RONALD PERELMAN—10.00K$4.99$49.91KBUY0.42%2.40MApr 08View
Apr 05, 2016RONALD PERELMAN—400.00K$5.20$2.08MBUY20.09%2.39MApr 01 - Apr 05View
Mar 30, 2016Paul G Savas—10.00K$5.34$53.45KBUY24.08%51.52KMar 28View
Mar 28, 2016RONALD PERELMAN—10.00K$5.64$56.44KBUY0.50%1.99MMar 24View
Mar 07, 2016Paul G Savas—21.52K$5.82$87.28KBUY107.61%41.52KMar 03 - Mar 07View
Feb 16, 2016RONALD PERELMAN—10.00K$5.83$58.25KBUY0.51%1.98MFeb 12View
Feb 05, 2016RONALD PERELMAN10% OWNER10.00K$6.43$64.26KBUY0.51%1.97MFeb 05View
Feb 04, 2016RONALD PERELMAN10% OWNER20.00K$6.05$121.03KBUY1.03%1.96MFeb 04View
Jan 20, 2016RONALD PERELMAN10% OWNER10.00K$6.58$65.79KBUY0.52%1.94MJan 15View
Jan 14, 2016RONALD PERELMAN10% OWNER15.00K$6.41$96.19KBUY0.78%1.93MJan 12 - Jan 13View
Dec 21, 2015RONALD PERELMAN10% OWNER15.00K$6.40$96.06KBUY0.79%1.92MDec 18View
Dec 16, 2015Joseph Noel SpiegelDIRECTOR5.71K$6.20$35.38KBUY1968.97%6.00KDec 15View
Nov 23, 2015Joseph Noel SpiegelDIRECTOR290.00$6.20$1.80KBUY∞290.00Nov 19View
Oct 02, 2015RONALD PERELMAN10% OWNER30.00K$6.26$187.82KBUY1.60%1.90MOct 01 - Oct 02View
Sep 29, 2015RONALD PERELMAN10% OWNER40.00K$6.04$241.41KBUY2.18%1.87MSep 25 - Sep 28View
Sep 28, 2015Paul G SavasDIRECTOR5.00K$6.62$33.12KBUY33.33%20.00KSep 25View
Sep 24, 2015RONALD PERELMAN10% OWNER24.00K$6.82$163.57KBUY1.33%1.83MSep 22View
Aug 11, 2015RONALD PERELMAN10% OWNER40.00K$8.81$352.37KBUY2.26%1.81MAug 07 - Aug 10View
Aug 05, 2015RONALD PERELMAN10% OWNER100.00K$10.00$1.00MBUY6.00%1.77MAug 04 - Aug 05View
Aug 05, 2015Paul G SavasDIRECTOR15.00K$15.00$225.00KBUY∞15.00KAug 04View
Aug 05, 2015Steven M. CohenDIRECTOR5.00K$15.00$75.00KBUY∞5.00KAug 04View
Aug 05, 2015Rudy HowardCFO & SECRETARY5.00K$15.00$75.00KBUY∞5.00KAug 04View
Aug 04, 2015RONALD PERELMAN10% OWNER1.67M$15.00$25.00MBUY∞1.67MAug 04View

FAQ

Q

Is insider trading legal?

A
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
Q

What are some examples of market manipulation?

A
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.

Browse insider trades on all stocks.

People Also Watch

Anixa Biosciences Inc
NASDAQ:ANIX
$3.28
0.61%
Connect Biopharma Holdings Ltd
NASDAQ:CNTB
$2.22
-3.48%
Inovio Pharmaceuticals Inc
NASDAQ:INO
$2.27
0.44%
Elicio Therapeutics Inc
NASDAQ:ELTX
$8.52
%
Fate Therapeutics Inc
NASDAQ:FATE
$1.10
-1.79%
Anika Therapeutics Inc
NASDAQ:ANIK
$9.57
%
Agenus Inc
NASDAQ:AGEN
$3.77
1.62%
Eledon Pharmaceuticals Inc
NASDAQ:ELDN
$1.65
0.61%
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2025 Benzinga | All Rights Reserved